封面
市场调查报告书
商品编码
1797893

全球虚拟实境创伤后压力症候群治疗市场:2032 年预测 - 按组件、治疗方法类型、应用、最终用户和地区进行分析

Virtual Reality Therapy for PTSD Market Forecasts to 2032 - Global Analysis By Component (Hardware, Software and Service), Therapy Type, Application, End User and By Geography

出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据,全球 PTSD 虚拟实境治疗市场预计在 2025 年达到 15.9 亿美元,到 2032 年将达到 59.4 亿美元,预测期内的复合年增长率为 20.7%。

一种名为虚拟实境疗法 (VRT) 的新型实证创伤后压力症候群 (PTSD) 疗法,利用身临其境型虚拟世界,帮助患者在安全、规范的环境中面对和处理创伤记忆。在合格治疗师的监督下,患者透过模拟与创伤事件极为相似的情境,逐渐接触令人不安的刺激。这有助于情绪处理,并减轻 PTSD 症状的严重程度。该方法将暴露疗法的概念与虚拟体验的有效性相结合,提供了一种客製化、更具娱乐性的替代传统谈话疗法的方案。

发表在《公共科学图书馆·综合》(PLOS ONE)上的系统综述发现,在纳入的十项研究中,有七项研究显示,虚拟实境暴露疗法 (VRET) 与观望对照组相比,在创伤后压力症候群 (PTSD) 症状方面具有统计学显着改善。这篇综述得出结论,VRET 与传统暴露疗法同样有效,尤其适用于对传统疗法有抵抗力的患者。

提高心理健康治疗的知识和采用率

全球对创伤后压力症候群(PTSD)等心理健康问题的认识日益加深,这推动了对虚拟实境疗法等尖端且便捷的治疗方法的需求。随着围绕精神疾病的污名逐渐消退,心理援助在公共论述中日益普及,人们寻求治疗的意愿也日益增强。 PTSD曾经被低估,如今在平民和军人中都已得到普遍认可,这使得对有效且扩充性的治疗模式的需求日益增长。此外,VR疗法也进一步推动了这一趋势,它提供了一种高科技、非侵入式的解决方案,既吸引了习惯使用科技的年轻一代,也吸引了寻求医疗替代方案的老年人。

缺乏临床通讯协定和标准化

目前尚无适用于 VR 疗法的 PTSD 治疗的广泛认可的临床指南、通讯协定或标准。虽然许多临床试验和试点计画已显示出良好的结果,但研究设计、治疗内容、治疗持续时间和治疗师参与度的差异使得结果难以比较或大规模复製。监管机构、保险公司和医疗专业人员都对这种不可预测性失去了信心。此外,缺乏标准化使得难以在不同的 VR 治疗平台上保持品管,从而可能危及患者安全和治疗效果。在与创伤倖存者和退伍军人等需要定期基于研究的干预的高危险群合作时,这个问题尤其严重。

扩展到平民创伤和创伤后压力症候群治疗环境

虽然我们最初的重点是军事相关的创伤后压力症候群 (PTSD),民营市场仍有巨大的未开发潜力。全球数百万人因暴力犯罪、自然灾害、性侵犯、事故和童年创伤而患有创伤后压力症候群,其中许多人缺乏适当的医疗或专科护理。透过模拟适合平民的特定创伤相关场景,我们可以客製化虚拟实境疗法并提供针对性治疗。此外,随着刑事司法、教育和社区健康机构对创伤知情护理的认识和接受度不断提高,VR 治疗平台拥有巨大的机会来拓展其应用范围,并惠及更广泛的非军事人群。

监管和核准复杂性的地区差异

数位疗法和基于虚拟实境的干预措施在不同国家和地区仍然面临着碎片化且不均衡的法规环境。儘管美国食品药物管理局(FDA)等机构已开始核准一些虚拟实境治疗应用,但大多数监管机构缺乏清晰的框架来评估和认证这些技术。希望进入国际市场的公司往往必须经历繁琐冗长的核准流程。此外,由于缺乏使用虚拟实境疗法治疗创伤后压力症候群(PTSD)的国际临床标准,这些平台更难在国际上扩张或被纳入政府资助的心理健康计画。

COVID-19的影响:

新冠疫情显着加速了创伤后压力症候群(PTSD)虚拟实境疗法市场的发展,凸显了对扩充性、技术主导的远距心理健康解决方案的迫切需求。 VR疗法已成为居家隔离期间面对面治疗的可行替代方案,提供减压技术和身临其境型暴露疗法,可透过便携式头戴设备远端进行,甚至可在临床环境中进行。疫情加剧了心理困扰,导致医护人员、重症疾病患者以及长期隔离或创伤的人群中PTSD病例增加。此外,心理健康服务需求的增加也为VR疗法提供者提供了拓展服务范围、与远端医疗平台建立新的合作伙伴关係以及获得更多资金的机会。

预计暴露疗法细分市场在预测期内将占最大份额

预计暴露疗法将在预测期内占据最大的市场占有率。这种主导地位源于其坚实的临床证据以及与身临其境型虚拟实境环境的兼容性,这使得患者能够透过可重复、可控的模拟来安全地处理和麵对创伤记忆。患有恐惧症和创伤相关创伤后压力症候群 (PTSD) 的患者、退伍军人和自然灾害倖存者都将从暴露疗法中受益匪浅。透过使传统的暴露疗法更加逼真和个人化,虚拟实境 (VR) 提高了患者的参与度和治疗效果。在针对 PTSD 市场的虚拟实境疗法中,基于 VR 的暴露疗法已成为最成熟和检验的治疗使用案例,并得到了大量临床研究的支持,并被心理健康专业人士广泛接受。

预计预测期内民事创伤部分将以最高的复合年增长率成长。

预计民间创伤治疗领域将在预测期内呈现最高成长率。非军事人群对心理健康问题的认识日益提高,以及与性侵犯、家庭暴力、事故和自然灾害相关的创伤后压力症候群 (PTSD) 确诊病例的增加,推动了这一增长。与军事创伤后压力症候群 (PTSD) 不同,受疫情后压力源影响的儿童、妇女和第一线工作人员是受民间创伤治疗影响最大的人群。虚拟实境 (VR) 非常适合民用 PTSD 治疗,因为它可以在受控环境中重现各种创伤场景。此外,基于 VR 的 PTSD 治疗在平民中越来越受欢迎,随着人们对心理健康的污名化逐渐减少,以及透过远端医疗和行动VR平台获得治疗的机会不断增加,推动了市场的显着增长。

比最大的地区

预计北美将在预测期内占据最大的市场占有率,这主要归功于其完善的医疗保健体系、较高的创伤后压力症候群发病率以及数位健康工具的广泛采用。美国是该地区的领导者,这得益于对退伍军人医疗保健的大量投资、心理健康宣导活动以及在军事和临床环境中采用虚拟实境疗法。美国退伍军人事务部和领先的研究型大学等组织为基于虚拟实境的创伤后压力症候群治疗的检验和实施提供了极大的帮助。此外,关键虚拟实境疗法开发人员的存在和有利的报销结构进一步巩固了美国作为创伤后压力症候群虚拟实境疗法领先市场的地位。

复合年增长率最高的地区:

预计亚太地区在预测期内将呈现最高的复合年增长率,这得益于创伤相关疾病患病率的上升、技术的快速普及以及人们对心理健康问题的认识不断提高。政府计画和官民合作关係正在扩大心理服务的可近性,而中国、日本、韩国和印度等国家正在大力投资数位医疗基础设施。该地区人口众多、智慧型手机和虚拟实境设备的普及率不断提高以及对远端医疗解决方案的接受度也推动了这一增长。此外,虚拟实境作为一种可扩展且经济实惠的创伤后压力症候群(PTSD)治疗方案,正在亚太地区推广。这是由于疫情后人们对心理健康的关注度不断提高,以及农村地区获得治疗的难度增加。

免费客製化服务

此报告的订阅者可以从以下免费自订选项中选择一项:

  • 公司简介
    • 对最多三家其他公司进行全面分析
    • 主要企业的SWOT分析(最多3家公司)
  • 区域分类
    • 根据客户兴趣对主要国家进行的市场估计、预测和复合年增长率(註:基于可行性检查)
  • 竞争基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第 2 章 简介

  • 概述
  • 相关利益者
  • 分析范围
  • 分析方法
    • 资料探勘
    • 数据分析
    • 数据检验
    • 分析方法
  • 分析材料
    • 主要研究资料
    • 二手研究资讯来源
    • 先决条件

第三章市场走势分析

  • 介绍
  • 驱动程式
  • 抑制因素
  • 市场机会
  • 威胁
  • 应用分析
  • 最终用户分析
  • 新兴市场
  • COVID-19的感染疾病

第四章 波特五力分析

  • 供应商的议价能力
  • 买方的议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争对手之间的竞争

5. 全球虚拟实境治疗创伤后压力症候群市场(按组成部分)

  • 硬体
    • VR头戴装置(HMD)
    • 触觉回馈设备
    • 运动追踪系统
  • 软体
    • 治疗模拟平台
    • 人工智慧个人化引擎
    • 云端基础的监控和数据分析工具
  • 服务
    • 提供远端医疗
    • 技术支援和维护
    • 数据分析和报告

6. 全球虚拟实境创伤后压力症候群治疗市场(依治疗方法类型)

  • 暴露疗法
  • 认知行为治疗(CBT)
  • 压力免疫训练
  • EMDR(眼动减敏与再处理)
  • 以正念为基础的VR疗法
  • 生物回馈疗法整合
  • 其他治疗方法

7. 全球虚拟实境治疗创伤后压力症候群市场(按应用)

  • 军事创伤
  • 平民创伤
  • 恐惧症
  • 忧郁症和压力管理
  • 其他用途

8. 全球虚拟实境治疗创伤后压力症候群市场(按最终用户)

  • 医院和诊所
  • 军事/国防
  • 心理健康中心
  • 復健中心
  • 研究所
  • 家庭治疗

9. 全球虚拟实境治疗创伤后压力症候群(PTSD)市场(按地区)

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 其他南美
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲地区

第十章:关键趋势

  • 合约、商业伙伴关係和合资企业
  • 企业合併与收购(M&A)
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第十一章 公司概况

  • Psious Inc
  • AppliedVR Inc.
  • XRHealth Inc.
  • Oxford VR
  • Pear Therapeutics
  • Virtually Better, Inc.
  • BehaVR
  • MindMaze Inc
  • Cognihab
  • Realiteer
  • Limbix
  • Emteq Labs
  • ImmersiveTouch Inc
Product Code: SMRC30263

According to Stratistics MRC, the Global Virtual Reality Therapy for PTSD Market is accounted for $1.59 billion in 2025 and is expected to reach $5.94 billion by 2032 growing at a CAGR of 20.7% during the forecast period. A new, evidence-based treatment for PTSD called virtual reality therapy (VRT) uses immersive virtual worlds to help people face and process traumatic memories in a safe and regulated environment. Under the supervision of a qualified therapist, patients are gradually exposed to upsetting stimuli by simulating situations that closely resemble the traumatic event. This helps with emotional processing and lessens the severity of PTSD symptoms. This method offers a customized and frequently more entertaining substitute for conventional talk therapy by fusing the ideas of exposure therapy with the effectiveness of virtual immersion.

According to a systematic review published in PLOS ONE, Virtual Reality Exposure Therapy (VRET) showed statistically significant improvements in PTSD symptoms compared to waitlist controls in 7 out of 10 studies reviewed. The review concluded that VRET is as effective as traditional exposure therapy and may be especially beneficial for patients resistant to conventional methods.

Market Dynamics:

Driver:

Growing knowledge and adoption of mental health treatments

Growing awareness of mental health issues, such as PTSD, around the world is fueling the need for cutting-edge, easily accessible treatment approaches like virtual reality therapy. Individuals are more willing to seek therapy as the stigma associated with mental illness gradually diminishes and psychological assistance becomes more commonplace in public discourse. Once underdiagnosed, PTSD is now commonly acknowledged in both civilian and military populations, and there has never been a more pressing need for effective, scalable treatment models. Additionally, this trend is supported by VR therapy, which provides a high-tech, non-invasive solution that appeals to both younger generations who are accustomed to using technology and older adults looking for alternatives to medicine.

Restraint:

Absence of clinical protocols and standardization

There aren't any widely recognized clinical guidelines, protocols, or standards for treating PTSD that apply to VR therapy. Although many clinical trials and pilot programs yield encouraging results, it is challenging to compare outcomes or replicate results on a large scale due to the variation in study designs, therapeutic content, treatment duration, and therapist involvement. Regulatory bodies, insurers, and medical professionals all lose faith in this unpredictability. Furthermore, lack of standardization makes it challenging to maintain quality control across various VR therapy platforms, which may jeopardize patient safety and therapeutic efficacy. This is particularly troubling when working with high-risk groups like trauma survivors or veterans, who might need regular, research-based interventions.

Opportunity:

Extension to civilian trauma and PTSD treatment environments

Although the first focus has been on PTSD related to the military, there is a lot of unrealized potential in the civilian market. Millions of people worldwide suffer from PTSD brought on by violent crimes, natural disasters, sexual assault, accidents, or childhood trauma, but many do not receive proper or specialized treatment. By simulating particular trauma-related settings that are pertinent to civilian populations, virtual reality therapy can be customized to provide targeted treatment. Moreover, VR therapy platforms have a great chance to broaden their applications and reach more people outside of the military as criminal justice, education, and community health settings become more conscious of and accepting of trauma-informed care.

Threat:

Regional differences in regulatory and approval complexities

Digital therapies and VR-based interventions continue to face a fragmented and uneven regulatory environment across various nations and regions. The majority of regulatory bodies lack clear frameworks for assessing and certifying these technologies, even though organizations like the U.S. FDA are starting to approve some VR therapy applications. Businesses that want to expand into foreign markets frequently have to deal with onerous and drawn-out approval a procedure, which adds to expenses and raises legal questions. Furthermore, it is more difficult for platforms to expand internationally or be incorporated into government-funded mental health programs when there are no international clinical standards for the use of VR therapy in the treatment of PTSD.

Covid-19 Impact:

The market for virtual reality therapy for PTSD was greatly accelerated by the COVID-19 pandemic, which brought attention to the pressing need for scalable, technology-driven, remote mental health solutions. VR therapy became a feasible substitute for in-person therapy sessions during lockdowns, providing stress-reduction techniques and immersive exposure therapy that could be administered remotely via portable headsets or even in clinical settings. PTSD cases among healthcare workers, survivors of severe illness, and people who have experienced prolonged isolation or trauma have increased as a result of the pandemic's escalation of psychological distress. Moreover, the increased demand for mental health services gave VR therapy providers the chance to broaden their services, establish new alliances with telehealth platforms, and secure more funding.

The exposure therapy segment is expected to be the largest during the forecast period

The exposure therapy segment is expected to account for the largest market share during the forecast period. This dominance is a result of its solid clinical basis and compatibility with immersive virtual reality environments, which enable patients to safely process and confront traumatic memories through repeatable, controlled simulations. People with PTSD that is phobia- or trauma-related, combat veterans and survivors of natural disasters all benefit greatly from exposure therapy. By making traditional exposure more realistic and personalized, virtual reality (VR) improves patient engagement and treatment results. Within the PTSD market for virtual reality therapy, VR-based exposure therapy has emerged as the most well-established and validated therapeutic use case, supported by a wealth of clinical research and widely embraced by mental health practitioners.

The civilian trauma segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the civilian trauma segment is predicted to witness the highest growth rate. Rising awareness of mental health concerns among non-military populations and an increase in PTSD diagnoses connected to sexual assault, domestic abuse, accidents, and natural disasters are driving this growth. Children, women, and frontline workers impacted by post-pandemic stressors are among the larger demographics affected by civilian trauma, in contrast to military PTSD. Virtual reality is ideally suited for treating civilian PTSD due to its ability to replicate a variety of trauma scenarios in a controlled environment. Moreover, VR-based PTSD treatment is becoming increasingly popular among civilians, which is propelling significant market growth as mental health stigma decreases and access to therapy increases through telehealth and mobile VR platforms.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share, mainly because of its sophisticated healthcare system, high PTSD rate, and robust use of digital health tools. Due to large investments in veteran healthcare, mental health awareness initiatives, and the incorporation of virtual reality therapy into military and clinical settings, the United States is the region leader. The validation and implementation of VR-based PTSD treatments have been greatly aided by organizations like the U.S. Department of Veterans Affairs and top research universities. Additionally, North America's position as the leading market for VR therapy aimed at PTSD is further reinforced by the existence of significant VR therapy developers and advantageous reimbursement structures.

Region with highest CAGR:

Over the forecast period, the Asia-Pacific region is anticipated to exhibit the highest CAGR, driven by a rise in the prevalence of trauma-related disorders, a rapid adoption of technology, and a growing awareness of mental health issues. While government programs and public-private partnerships are increasing access to psychological services, nations such as China, Japan, South Korea, and India are making significant investments in digital healthcare infrastructure. The surge is also attributed to the region's large population, increasing use of smartphones and virtual reality devices, and receptiveness to telemedicine solutions. Furthermore, VR is being promoted as a scalable and affordable PTSD treatment option throughout Asia-Pacific due to the post-pandemic emphasis on mental wellness and the difficulty of accessing therapy in rural areas.

Key players in the market

Some of the key players in Virtual Reality Therapy for PTSD Market include Psious Inc, AppliedVR Inc., XRHealth Inc., Oxford VR, Pear Therapeutics, Virtually Better, Inc., BehaVR, MindMaze Inc, Cognihab, Realiteer, Limbix, Emteq Labs and ImmersiveTouch Inc.

Key Developments:

In February 2025, XRHealth, a provider of therapeutic virtual reality (VR), mixed reality (MR), and extended reality (XR) solutions, has this week announced that it has acquired digital therapeutics company RealizedCare. Outcome Capital served as strategic and financial advisor for the acquisition. The RealizedCare platform of immersive digital therapeutics addresses chronic pain and mental health challenges through evidence-based CBT and biopsychosocial protocols.

In July 2024, ImmersiveTouch Inc announced that its groundbreaking augmented reality (AR) technology platform, ImmersiveAR, has received 510(k) clearance for clinical use in the operating room by the U.S. Food and Drug Administration (FDA). The Chicago-based company will commence immediate commercialization of the platform in the United States.

In November 2023, BehaVR and Fern Health announced the signing of an agreement to merge their businesses and create a new digital care management solution for chronic pain. The new offering will be branded as RealizedCare, and strives to meet the increased demand for evidence-based, more scalable, impactful and economically viable solutions for a range of mental and behavioral health burdens, beginning with chronic pain.

Components Covered:

  • Hardware
  • Software
  • Service

Therapy Types Covered:

  • Exposure Therapy
  • Cognitive Behavioral Therapy (CBT)
  • Stress Inoculation Training
  • EMDR (Eye Movement Desensitization and Reprocessing)
  • Mindfulness-Based VR Therapy
  • Biofeedback Integration
  • Other Threapy Types

Applications Covered:

  • Military Trauma
  • Civilian Trauma
  • Phobias
  • Depression & Stress Management
  • Other Applications

End Users Covered:

  • Hospitals & Clinics
  • Military & Defense
  • Mental Health Centers
  • Rehabilitation Centers
  • Research Institutes
  • Home-Based Therapy

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Application Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Virtual Reality Therapy for PTSD Market, By Component

  • 5.1 Introduction
  • 5.2 Hardware
    • 5.2.1 VR Headsets (HMDs)
    • 5.2.2 Haptic Feedback Devices
    • 5.2.3 Motion Tracking Systems
  • 5.3 Software
    • 5.3.1 Therapy Simulation Platforms
    • 5.3.2 AI-Powered Personalization Engines
    • 5.3.3 Cloud-Based Monitoring & Data Analytics Tools
  • 5.4 Service
    • 5.4.1 Remote Therapy Delivery
    • 5.4.2 Technical Support & Maintenance
    • 5.4.3 Data Analytics & Reporting

6 Global Virtual Reality Therapy for PTSD Market, By Therapy Type

  • 6.1 Introduction
  • 6.2 Exposure Therapy
  • 6.3 Cognitive Behavioral Therapy (CBT)
  • 6.4 Stress Inoculation Training
  • 6.5 EMDR (Eye Movement Desensitization and Reprocessing)
  • 6.6 Mindfulness-Based VR Therapy
  • 6.7 Biofeedback Integration
  • 6.8 Other Threapy Types

7 Global Virtual Reality Therapy for PTSD Market, By Application

  • 7.1 Introduction
  • 7.2 Military Trauma
  • 7.3 Civilian Trauma
  • 7.4 Phobias
  • 7.5 Depression & Stress Management
  • 7.6 Other Applications

8 Global Virtual Reality Therapy for PTSD Market, By End User

  • 8.1 Introduction
  • 8.2 Hospitals & Clinics
  • 8.3 Military & Defense
  • 8.4 Mental Health Centers
  • 8.5 Rehabilitation Centers
  • 8.6 Research Institutes
  • 8.7 Home-Based Therapy

9 Global Virtual Reality Therapy for PTSD Market, By Geography

  • 9.1 Introduction
  • 9.2 North America
    • 9.2.1 US
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 Italy
    • 9.3.4 France
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 New Zealand
    • 9.4.6 South Korea
    • 9.4.7 Rest of Asia Pacific
  • 9.5 South America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Chile
    • 9.5.4 Rest of South America
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 Qatar
    • 9.6.4 South Africa
    • 9.6.5 Rest of Middle East & Africa

10 Key Developments

  • 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 10.2 Acquisitions & Mergers
  • 10.3 New Product Launch
  • 10.4 Expansions
  • 10.5 Other Key Strategies

11 Company Profiling

  • 11.1 Psious Inc
  • 11.2 AppliedVR Inc.
  • 11.3 XRHealth Inc.
  • 11.4 Oxford VR
  • 11.5 Pear Therapeutics
  • 11.6 Virtually Better, Inc.
  • 11.7 BehaVR
  • 11.8 MindMaze Inc
  • 11.9 Cognihab
  • 11.10 Realiteer
  • 11.11 Limbix
  • 11.12 Emteq Labs
  • 11.13 ImmersiveTouch Inc

List of Tables

  • Table 1 Global Virtual Reality Therapy for PTSD Market Outlook, By Region (2024-2032) ($MN)
  • Table 2 Global Virtual Reality Therapy for PTSD Market Outlook, By Component (2024-2032) ($MN)
  • Table 3 Global Virtual Reality Therapy for PTSD Market Outlook, By Hardware (2024-2032) ($MN)
  • Table 4 Global Virtual Reality Therapy for PTSD Market Outlook, By VR Headsets (HMDs) (2024-2032) ($MN)
  • Table 5 Global Virtual Reality Therapy for PTSD Market Outlook, By Haptic Feedback Devices (2024-2032) ($MN)
  • Table 6 Global Virtual Reality Therapy for PTSD Market Outlook, By Motion Tracking Systems (2024-2032) ($MN)
  • Table 7 Global Virtual Reality Therapy for PTSD Market Outlook, By Software (2024-2032) ($MN)
  • Table 8 Global Virtual Reality Therapy for PTSD Market Outlook, By Therapy Simulation Platforms (2024-2032) ($MN)
  • Table 9 Global Virtual Reality Therapy for PTSD Market Outlook, By AI-Powered Personalization Engines (2024-2032) ($MN)
  • Table 10 Global Virtual Reality Therapy for PTSD Market Outlook, By Cloud-Based Monitoring & Data Analytics Tools (2024-2032) ($MN)
  • Table 11 Global Virtual Reality Therapy for PTSD Market Outlook, By Service (2024-2032) ($MN)
  • Table 12 Global Virtual Reality Therapy for PTSD Market Outlook, By Remote Therapy Delivery (2024-2032) ($MN)
  • Table 13 Global Virtual Reality Therapy for PTSD Market Outlook, By Technical Support & Maintenance (2024-2032) ($MN)
  • Table 14 Global Virtual Reality Therapy for PTSD Market Outlook, By Data Analytics & Reporting (2024-2032) ($MN)
  • Table 15 Global Virtual Reality Therapy for PTSD Market Outlook, By Therapy Type (2024-2032) ($MN)
  • Table 16 Global Virtual Reality Therapy for PTSD Market Outlook, By Exposure Therapy (2024-2032) ($MN)
  • Table 17 Global Virtual Reality Therapy for PTSD Market Outlook, By Cognitive Behavioral Therapy (CBT) (2024-2032) ($MN)
  • Table 18 Global Virtual Reality Therapy for PTSD Market Outlook, By Stress Inoculation Training (2024-2032) ($MN)
  • Table 19 Global Virtual Reality Therapy for PTSD Market Outlook, By EMDR (Eye Movement Desensitization and Reprocessing) (2024-2032) ($MN)
  • Table 20 Global Virtual Reality Therapy for PTSD Market Outlook, By Mindfulness-Based VR Therapy (2024-2032) ($MN)
  • Table 21 Global Virtual Reality Therapy for PTSD Market Outlook, By Biofeedback Integration (2024-2032) ($MN)
  • Table 22 Global Virtual Reality Therapy for PTSD Market Outlook, By Other Threapy Types (2024-2032) ($MN)
  • Table 23 Global Virtual Reality Therapy for PTSD Market Outlook, By Application (2024-2032) ($MN)
  • Table 24 Global Virtual Reality Therapy for PTSD Market Outlook, By Military Trauma (2024-2032) ($MN)
  • Table 25 Global Virtual Reality Therapy for PTSD Market Outlook, By Civilian Trauma (2024-2032) ($MN)
  • Table 26 Global Virtual Reality Therapy for PTSD Market Outlook, By Phobias (2024-2032) ($MN)
  • Table 27 Global Virtual Reality Therapy for PTSD Market Outlook, By Depression & Stress Management (2024-2032) ($MN)
  • Table 28 Global Virtual Reality Therapy for PTSD Market Outlook, By Other Applications (2024-2032) ($MN)
  • Table 29 Global Virtual Reality Therapy for PTSD Market Outlook, By End User (2024-2032) ($MN)
  • Table 30 Global Virtual Reality Therapy for PTSD Market Outlook, By Hospitals & Clinics (2024-2032) ($MN)
  • Table 31 Global Virtual Reality Therapy for PTSD Market Outlook, By Military & Defense (2024-2032) ($MN)
  • Table 32 Global Virtual Reality Therapy for PTSD Market Outlook, By Mental Health Centers (2024-2032) ($MN)
  • Table 33 Global Virtual Reality Therapy for PTSD Market Outlook, By Rehabilitation Centers (2024-2032) ($MN)
  • Table 34 Global Virtual Reality Therapy for PTSD Market Outlook, By Research Institutes (2024-2032) ($MN)
  • Table 35 Global Virtual Reality Therapy for PTSD Market Outlook, By Home-Based Therapy (2024-2032) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.